凯撒娱乐 CZR 深 沪
已收盘 02-06 16:00:00 美东时间
20.52
+0.210
+1.03%
华盛通- 最 高21.10
- 今 开20.35
- 成交量 1126.46万股
- 最 低 20.12
- 昨 收 20.31
- 总市值 41.88亿
- 52周最高 39.86
- 市盈率 静 --
- 换手率 5.52%
- 52周最低 18.25
- 委 比 16.43%
- 总股本 2.04亿
- 历史最高 119.81
- 量 比 1.55
- 振 幅 4.83%
- 历史最低 3.22
- 每 手 1
- 风险率 3.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Las Vegas Strip gaming revenue falls again on weak slot numbers
Gaming win on the Las Vegas Strip fell 6.1% in December to $827.7M on a year-over-year comparison. The report from the Nevada Gaming Control Board confirmed that headwinds such as pricing concerns and...
01-28 23:44
DraftKings, Flutter In Focus As BofA Sees Online Betting Driving Gaming Stocks Into 2026
Online sports betting remains the key driver for gaming stocks; DraftKings positioned for upside while FanDuel faces mixed demand trends.
01-23 00:55
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX Jan 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including IBM, KLA and WEX, on Wednesday. HIGHLIGHTS * IBM IBM.N : JP Morgan raises target price to $312 from $290 * KLA Corp KLAC.O : Deut
01-21 16:26
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
Morgan Stanley Maintains Equal-Weight on Caesars Entertainment, Lowers Price Target to $27
Morgan Stanley analyst Stephen Grambling maintains Caesars Entertainment (NASDAQ:CZR) with a Equal-Weight and lowers the price target from $29 to $27.
01-17 01:08
Barclays Reaffirms Their Buy Rating on Caesars Entertainment (CZR)
In a report released today, Brandt Montour from Barclays maintained a Buy ratin...
01-16 16:58
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Caesars rallies after Susquehanna turns bullish on the 2026 setup
Susquehanna upgraded Caesars Entertainment (CZR) to a Positive rating after having the casino stock slotted at Neutral. As part of its valuation call, the firm maintains that the stock’s risk-reward p...
01-09 01:07
Susquehanna Upgrades Caesars Entertainment to Positive, Raises Price Target to $31
Susquehanna analyst Joseph Stauff upgrades Caesars Entertainment (NASDAQ:CZR) from Neutral to Positive and raises the price target from $25 to $31.
01-08 20:47
